Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma

Por Kim, Hyunki, Zhai, Guihua, Samuel, Sharon L., Rigell, Christopher J., Umphrey, Heidi R., Rana, Samir, Stockard, Cecil R., Fineberg, Naomi S., Zinn, Kurt R.
Publicado em 2011

Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer

Por Kim, Hyunki, Samuel, Sharon L, Zhai, Guihua, Rana, Samir, Taylor, Marie, Umphrey, Heidi R, Oelschlager, Denise K, Buchsbaum, Donald J, Zinn, Kurt R
Publicado em 2014

Serial Passage through Human Glioma Xenografts Selects for a Δγ(1)34.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with E...

Por Shah, Amish C., Price, Kathleen H., Parker, Jacqueline N., Samuel, Sharon L., Meleth, Sreelatha, Cassady, Kevin A., Yancey Gillespie, G., Whitley, Richard J., Markert, James M.
Publicado em 2006

SPARC independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic cancer xenografts

Por Kim, Harrison, Samuel, Sharon L., Lopez-Casas, Pedro P., Grizzle, William E., Hidalgo, Manuel, Kovar, Joy, Oelschlager, Denise K., Zinn, Kurt R., Warram, Jason M., Buchsbaum, Donald J.
Publicado no Mol Cancer Ther (2016)

Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers

Por Kim, Hyunki, Rigell, Christopher J., Zhai, Guihua, Lee, S. Kyle, Samuel, Sharon L., Martin, Amber, Umphrey, Heidi R., Stockard, Cecil R., Beasley, T. Mark, Buchsbaum, Donald J., Li, Long Shan, Boothman, David A., Zinn, Kurt R.
Publicado em 2013

A ferret model of COPD-related chronic bronchitis

Por Raju, S. Vamsee, Kim, Hyunki, Byzek, Stephen A., Tang, Li Ping, Trombley, John E., Jackson, Patricia, Rasmussen, Lawrence, Wells, J. Michael, Libby, Emily Falk, Dohm, Erik, Winter, Lindy, Samuel, Sharon L., Zinn, Kurt R., Blalock, J. Edwin, Schoeb, Trenton R., Dransfield, Mark T., Rowe, Steven M.
Publicado no JCI Insight (2016)